泰爾股份(002347.SZ):邰正彪辭去總經理職務 邰紫鵬繼任
格隆匯 8 月 7日丨泰爾股份(002347.SZ)公佈,為了保持企業健康可持續發展,公司董事長、總經理邰正彪申請本人辭去總經理職務,並提名邰紫鵬為公司總經理。經董事會提名委員會審核,第五屆董事會第六次會議審議通過,同意聘任邰紫鵬先生為公司總經理,任期與第五屆董事會任期一致。
邰正彪辭去總經理職務後,仍擔任公司董事長及董事會專門委員會等相關職務。
邰紫鵬具備上市公司運作的基本知識,熟悉相關法律、行政法規、規章及其他規範性文件,其學歷、專業知識、工作經歷和能力、經營管理經驗,能夠勝任公司總經理崗位的職責要求,任職資格符合《公司法》和《公司章程》的規定。我們同意聘任邰紫鵬為公司總經理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.